IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Fredi, Micaela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.010
EU - Europa 1.429
AS - Asia 594
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
AF - Africa 2
Totale 6.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.000
CN - Cina 354
UA - Ucraina 351
DE - Germania 280
IT - Italia 232
HK - Hong Kong 186
FI - Finlandia 126
GB - Regno Unito 110
IE - Irlanda 100
PL - Polonia 63
FR - Francia 55
RU - Federazione Russa 35
SE - Svezia 32
IN - India 17
BE - Belgio 12
VN - Vietnam 12
CA - Canada 10
AU - Australia 7
MK - Macedonia 7
SG - Singapore 6
TR - Turchia 6
NL - Olanda 5
ES - Italia 4
EU - Europa 3
GR - Grecia 3
PK - Pakistan 3
RS - Serbia 3
SA - Arabia Saudita 3
BR - Brasile 2
CH - Svizzera 2
PH - Filippine 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 6.049
Salva come PNG Salva come JPEG
Città #
Fairfield 705
Woodbridge 472
Ashburn 339
Houston 290
Jacksonville 281
Cambridge 261
Seattle 227
Chandler 214
Wilmington 212
Ann Arbor 211
Hong Kong 186
Princeton 169
Helsinki 108
New York 106
Dublin 100
Beijing 70
Nanjing 68
Warsaw 63
Brescia 47
San Diego 33
Shanghai 33
Nanchang 30
Des Moines 27
Shenyang 24
London 22
Hebei 21
San Francisco 19
Changsha 18
Jiaxing 16
Tianjin 14
Milan 13
Brussels 12
Cagliari 12
Dong Ket 12
Dearborn 10
Nürnberg 10
Rozzano 10
Hangzhou 9
Jinan 9
Lancaster 9
Los Angeles 9
Ningbo 9
Verona 9
Bergamo 8
Pune 8
Rome 7
Washington 7
Ferrara 6
Kilburn 6
Kunming 6
Orange 6
Ottawa 6
Pordenone 6
Lanzhou 5
Norwalk 5
Prescot 5
Zhengzhou 5
Falkenstein 4
Melbourne 4
Strasbourg 4
Turin 4
Boardman 3
Duncan 3
Indiana 3
New Bedfont 3
Novi Sad 3
Redwood City 3
Rho 3
Riyadh 3
Skopje 3
Acton 2
Amsterdam 2
Atlanta 2
Augusta 2
Changchun 2
Chiswick 2
Clearwater 2
Cosenza 2
Crotone 2
Dallas 2
Frankfurt am Main 2
Fuzhou 2
Genoa 2
Haikou 2
Kocaeli 2
Markham 2
Motta Baluffi 2
Palermo 2
Paris 2
Passirano 2
Ponte San Pietro 2
Rawalpindi 2
Santa Cruz de Tenerife 2
Sydney 2
Toronto 2
Walnut 2
Alessandria 1
Auckland 1
Baotou 1
Bari 1
Totale 4.704
Salva come PNG Salva come JPEG
Nome #
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 159
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 152
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 134
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 127
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 124
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 123
Antiphospholipid antibodies mediate autoimmunity against dying cells. 122
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 118
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 118
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 117
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 116
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 113
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 113
The clinico-serological spectrum of overlap myositis 113
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 112
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 112
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 111
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 109
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 108
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 105
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 104
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 104
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 102
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 102
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 100
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 100
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 100
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 97
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 96
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 94
IRF5 is associated with primary antiphospholipid syndrome,but is not a major risk factor 93
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 89
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 87
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 86
Myositis autoantibodies and clinical phenotypes 84
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 83
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 83
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 80
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 77
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 71
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 71
ANTIPHOSPHOLIPID ANTIBODIES AND CEREBROVASCULAR EVENTS. WHICH FACTORS ASSOCIATE WITH ONSET AND RECURRENCE? - POSTER TOURS 70
Should we treat congenital heart block with fluorinated corticosteroids? 68
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 68
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 67
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 63
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 63
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 59
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 59
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 58
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 57
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 55
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis 54
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry 54
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 53
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 53
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 52
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 48
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 47
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 45
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 40
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 39
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 38
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 37
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 36
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 34
Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study 34
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications 29
Managing puerperium in patients with systemic autoimmune diseases: an update 29
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 28
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 27
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 26
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 26
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 26
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 26
Neutrophil Extracellular Traps in the Autoimmunity Context. 23
Autoimmune polyglandular syndrome type 4: experience from a single reference center 22
Association of Natural Killer Cell Ligand Polymorphism, HLAC Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block 21
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 17
Systemic lupus erythematosus: state of the art on clinical practice guidelines 16
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 15
Systemic Vasculitis and Pregnancy 15
Obstetric APS 14
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women 14
Topoisomerase I (SCL 70) Autoantibodies 14
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 14
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 13
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 13
Identifying and managing lupus nephritis during pregnancy 13
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 12
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 11
Typing TREX1 gene in patients with systemic lupus erythematosus 11
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 11
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 11
What is the best instrument to measure disease activity in SLE? - SLE-DAS vs easy BILAG 10
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 9
Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohortof 214 patients 9
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 9
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 8
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 7
Totale 6.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019390 0 0 0 0 0 0 0 0 0 89 157 144
2019/20201.542 197 59 61 189 104 164 146 167 152 170 51 82
2020/20211.318 26 148 66 134 82 186 51 135 118 181 93 98
2021/2022765 66 81 54 40 12 54 26 59 43 95 70 165
2022/2023730 100 7 9 42 74 201 11 88 121 5 34 38
2023/2024767 54 21 77 111 56 150 36 49 196 17 0 0
Totale 6.236